These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6966340

  • 21. [Treatment of advanced cervical cancer with sequential administration of OK-432].
    Yakabe A, Sugino N, Yamashita S, Kinashi N, Ito T, Kamei T, Takasaki A.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1911-4. PubMed ID: 3209918
    [No Abstract] [Full Text] [Related]

  • 22. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 9. Effect of the mitomycin C-treated, cryopreserved immune reaction combined with biological response modifier, OK-432].
    Ogawa Y, Maeda T, Yoshida S, Yamamoto Y, Morita M, Ogawa Y, Imanaka K, Gose K, Imajo Y, Kimura S.
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun 20; 18(4):946-50. PubMed ID: 6413627
    [No Abstract] [Full Text] [Related]

  • 23. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
    Kodama M, Tanaka T.
    Hiroshima J Med Sci; 1983 Jun 20; 32(2):167-71. PubMed ID: 6618899
    [No Abstract] [Full Text] [Related]

  • 24. Histological effect of intranodal injection of the streptococcal preparation OK-432 for cervical lymph node metastases of malignant head and neck tumors.
    Suzuki K, Tsuge I, Ito Y, Kunii H, Baba S.
    Acta Otolaryngol Suppl; 1996 Jun 20; 525():125-8. PubMed ID: 8908286
    [Abstract] [Full Text] [Related]

  • 25. Immunochemotherapy in human hepatocellular carcinoma using the streptococcal agent OK-432.
    Imaoka S, Sasaki Y, Ishikawa O, Ouhigashi H, Koyama H, Iwanaga T, Ishiguro S.
    J Clin Oncol; 1986 Nov 20; 4(11):1645-51. PubMed ID: 2430071
    [Abstract] [Full Text] [Related]

  • 26. [Intraepithelial lymphocytes (IEL) in murine ocular surface epithelium and effects of the topical application of OK-432 and interleukin-2].
    Tagawa Y, Takeuchi T, Saito M, Saga T, Matsuda H.
    Nippon Ganka Gakkai Zasshi; 1985 Jul 20; 89(7):832-7. PubMed ID: 3877407
    [No Abstract] [Full Text] [Related]

  • 27. The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.
    Toge T, Kuninobu H, Yamaguchi Y, Baba N, Kegoya Y, Hattori T.
    Jpn J Surg; 1988 Nov 20; 18(6):668-74. PubMed ID: 3266768
    [Abstract] [Full Text] [Related]

  • 28. [Immunochemotherapy using OK-432 in gestational choriocarcinoma].
    Kanazawa K, Ohno M, Takeuchi S.
    Nihon Gan Chiryo Gakkai Shi; 1982 Oct 20; 17(7):1902-7. PubMed ID: 6891714
    [No Abstract] [Full Text] [Related]

  • 29. [Cytologic changes following intratumoral high dose injection of OK-432 in advanced pancreatic cancers and gall bladder cancers with ultrasound guidance].
    Okano Y, Takenaka A, Kasugai H, Morii T, Kishigami Y, Okuda S.
    Gan To Kagaku Ryoho; 1983 Aug 20; 10(8):1892-3. PubMed ID: 6882009
    [No Abstract] [Full Text] [Related]

  • 30. [The clinical effect of concomitant use of non-specific immunopotentiator OK-432 on primary lung cancer treated with radiation combined with chemotherapy].
    Ogawa Y, Kimura S, Imajo Y, Imanaka K, Gose K.
    Nihon Gan Chiryo Gakkai Shi; 1982 Oct 20; 17(7):1949-56. PubMed ID: 7161555
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical investigation of intratumoral OK-432 administration].
    Shimada K, Tabuse K, Kono N, Katsumi M, Yamamoto H, Yamamoto Y, Endo A.
    Gan To Kagaku Ryoho; 1983 Aug 20; 10(8):1844-9. PubMed ID: 6882008
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of streptococcal preparation OK-432 for gastric cancer patients--comparison between intradermal and intramuscular injection.
    Hanaue H, Kurosawa T, Yoshizaki S, Shikata J.
    Jpn J Surg; 1984 May 20; 14(3):191-7. PubMed ID: 6611437
    [Abstract] [Full Text] [Related]

  • 33. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M.
    Cancer Res; 2004 Aug 01; 64(15):5461-70. PubMed ID: 15289356
    [Abstract] [Full Text] [Related]

  • 34. [Skin reaction to OK-432 and its dosage for locoregional administration].
    Yamaguchi Y, Noma K, Miyahara E, Funakoshi M, Takashima I, Kawami H, Sawamura A, Toge T.
    Gan To Kagaku Ryoho; 1994 Sep 01; 21(13):2108-10. PubMed ID: 7944414
    [Abstract] [Full Text] [Related]

  • 35. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T.
    Int J Oncol; 2004 Apr 01; 24(4):959-66. PubMed ID: 15010836
    [Abstract] [Full Text] [Related]

  • 36. Comparison of immunological responses and survival periods in cancer patients treated with intradermal and intramuscular injection of the streptococcal preparation OK-432.
    Hanaue H, Kurosawa T, Yasuda H, Yoshizaki S, Nomoto SN, Takada T, Shikata J.
    Keio J Med; 1984 Apr 01; 33(1):17-27. PubMed ID: 6482140
    [No Abstract] [Full Text] [Related]

  • 37. [Evaluation of intratumoral injection of an immunopotentiator (OK-432) in patients with hepatocellular carcinoma].
    Imaoka S, Sasaki Y, Matsui Y, Ishikawa O, Taniguchi K, Iwanaga T, Terasawa T.
    Nihon Gan Chiryo Gakkai Shi; 1982 Oct 20; 17(7):1957-62. PubMed ID: 6298326
    [No Abstract] [Full Text] [Related]

  • 38. [Intratumoral anti-cancer therapy by US guided puncture in advanced pancreatic cancer (author's transl)].
    Ryu M, Uematsu S, Watanabe Y, Furukawa T, Kikuchi T.
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep 20; 78(9):1818. PubMed ID: 7321279
    [No Abstract] [Full Text] [Related]

  • 39. [Combination therapy of large amount of carboquone and OK-432 for unresectable lung cancer].
    Nakarai I, Honda T, Jinnai S, Kita T, Shinoda A.
    Gan To Kagaku Ryoho; 1982 Jul 20; 9(6):1006-11. PubMed ID: 7184436
    [Abstract] [Full Text] [Related]

  • 40. [Prophylactic effect of OK-432 on serosal invasion in an experimental model of peritoneal dissemination].
    Iijima T, Miwa H, Sunami M, Ensako K, Yui J.
    Gan To Kagaku Ryoho; 1984 Apr 20; 11(4):956-7. PubMed ID: 6721510
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.